nobiletin has been researched along with Learning Disabilities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, A; Ohizumi, Y; Yamakuni, T | 1 |
| Matsuzaki, K; Mimaki, Y; Nakajima, A; Nakata, N; Ohizumi, Y; Onozuka, H; Sashida, Y; Yamakuni, T; Yokosuka, A | 1 |
1 review(s) available for nobiletin and Learning Disabilities
| Article | Year |
|---|---|
Pharmacological action of nobiletin, a component of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, and its application for development of functional foods.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; Flavones; Foods, Specialized; Hippocampus; Humans; Learning Disabilities; Memory Disorders; Mice; Neurons; Plants, Medicinal; Rats; Signal Transduction | 2008 |
1 other study(ies) available for nobiletin and Learning Disabilities
| Article | Year |
|---|---|
Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling.
Topics: Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Dizocilpine Maleate; Extracellular Signal-Regulated MAP Kinases; Flavones; Hippocampus; Learning Disabilities; Male; MAP Kinase Signaling System; Mice; Phosphorylation; Receptors, N-Methyl-D-Aspartate | 2007 |